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Abstract
Nuclear actin has been implicated in different nuclear functions. In this work, its localization in nuclear membrane, chromatin 
and nuclear lipid microdomains was investigated. The implication of sphingomyelin metabolism was studied.
Nuclear membrane, chromatin and nuclear lipid microdomains were purified from hepatocyte nuclei and H35 human he-
patoma cell nuclei. The presence of β-actin  was analyzed with immunoblotting by using specific antibodies. Sphingomyelina-
se, sphingomyelin-synthase, and phosphatidylcholine-specific phospholipase C activities were assayed by using radioactivity 
sphingomyelin and phosphatidylcholine as substrate.
The results showed that β-actin is localized in nuclear lipid microdomains and it increases in cancer cells. Evidence is pro-
vided to the difference of phosphatidylcholine and sphingomyelin metabolism in various subnuclear fractions of cancer cell 
nuclei compared with normal cells. Our findings show increase of sphingomyelin-synthase and inhibition of sphingomyelinase 
activity only in nuclear lipid microdomains. 
Nuclear lipid microdomains, constituted by phosphatidylcholine, sphingomyelin and cholesterol, play a role as platform for 
β-actin anchoring. Possible role of sphingomyelin metabolism in cancer cells is discussed.
Introduction
The actin is a structural protein underlying the proper development, cell size and shape 
and has a prominent influence on governing the molecular mechanism and regulating 
different cell functions (1). Six different isoforms of actin encoded by specific genes are 
present in mammals (2). In particular, α-skeletal actin is particularly expressed in skeletal 
muscle, α-cardiac actin in cardiac muscle, α-smooth actin and γ-smooth actin smooth 
muscle. β-cyto actin and γ-cyto actin are expressed in all tissue (3).  
The presence of β-actin in the nucleus has been a controversial issue for many years 
due to the hypothesis of possible contaminations during purification procedure (4). To-
day the presence and the role of actin in the nucleus is clear; it is present as a component 
of all three RNA polymerases,  as a constituent of nuclear ribonucleoprotein particles 
and as a regulatory component of chromatin remodeling (5). Nuclear actin is present in 
a monomeric state and influences its own polymerization state by binding transcriptional 
activators, which move between cytoplasm and the nucleus (4). It is present in nuclear 
complexes for DNA synthesis and chromatin remodeling and for nuclear import/export 
proteins, such as importin (4). The role of actin  in the activity of RNA polymerase II 
was described (6). The size of actin (approximately 42 kDa) does not permit the passive 
diffusion through the nuclear pore; exportin 6 permits the nuclear export of actin and 
importin 9 permits the maintenance of nuclear actin levels (7). In this way, actin may play 
a role as a sensor of extracellular signals in order to transduce signals to the chromatin 
state and moderate genome organization of living cells (5).
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Nuclear lipid microdomains (NLMs) are specific areas of 
inner nuclear membrane that act as platforms for chromatin 
anchoring (8), DNA duplication (9) and RNA transcription 
(10). In addition, NLMs regulate nuclear vitamin D3 uptake 
by influencing differentiation of embryonic hippocampal 
cells (11). In hepatoma cells, NLMs play a role  as resting 
place of dexamethasone to delay cell proliferation (12). 
NLMs are vesicle structures with 300-600 nm average di-
ameter; they contain cholesterol, phosphatidylcholine (PC) 
and sphingomyelin (SM) with 1:1:1 ratio similar to lipid rafts 
present in cell membrane (8). The SM metabolism in NLMs 
of normal liver was demonstrated (8) but until now we have 
no information on it in hepatoma cells. Nuclear SM is local-
ized in chromatin (Chr), nuclear membrane (NM), nuclear 
matrix (13) and in NLMs (8); it is synthesized by SM-syn-
thase (SM-synthase) and catabolized by sphingomyelinase 
(SMase, 13). 
Until now we do not have information about the localiza-
tion on nuclear actin. In this study, with the immunoblotting 
analysis that simultaneously show the β-actin in NM, Chr, 
and NLM, we demonstrate for the first time the specific lo-
calization of nuclear actin in NLM. We provide evidence that 
β-actin is higher in H35 hepatoma NLM than hepatocyte (H) 
NLM. Additionally, we used enzyme activity assay to study 
the SM and PC metabolism in different subnuclear fractions. 
Notably we demonstrate the higher activity of SM-synthase 
and lower activity of SMase in NLM from H35 cells than in 
NLM from H. The correlation between  β-actin  and SM me-
tabolism in NLM from normal and cancer cells is discussed.
  
Materials and Methods
Animals and Cells
Thirty-day-old Sprague Dawley rats of either sex (Harlan 
Nossan, Milan, Italy) kept at normal light-dark periods were 
used. They had free access to pelleted food and water prior to 
killing between 9 and 10 a.m. All treatments were made ac-
cording to the international regulation of National Institutes 
of Health. H35 hepatoma cells were obtained from the Eu-
ropean Collection of Animal Cell Cultures (Salisbury, Wilts, 
United Kingdom).
Materials
Dulbecco’s modified Eagle’s medium (DMEM), bovine se-
rum albumin (BSA), dithiothreitol, fetal bovine serum (FBS), 
phenylmethylsulfonylfluoride (PMSF), methanol, 3-(4,5-di-
methyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT),  2-propanol, metyl-tert-butyl ether, formic acid, and 
chloroform were obtained from Sigma Chemical Co. (St. 
Louis, Missouri, U.S.A.); PC (L-3-phosphatidyl N-methyl-3H 
choline 1,2 dipalmitoyl, 81.0 Ci/mmol) was from Amersh-
am Pharmacia Biotech (Rainham, Essex, UK); Ecoscint A 
was from National Diagnostic (Atlanta, Georgia, U.S.A); an-
ti-LaminB and anti-β-actin were obtained from Santa Cruz 
Biotechnology, Inc. (California, USA).   
Nuclei, nuclear membrane, chromatin and nuclear lipid 
microdomain purification
For H nuclei preparation, rat liver was homogenized, filtered 
and nuclei were isolated as previously reported (14).  For hepa-
toma cell nuclei preparation, H35 hepatoma cells were seeded, 
cultured and N were isolated according to Albi et al., 2005 (15). 
NM and Chr were purified as previously reported (16). NLM 
were purified as reported by Cascianelli et al., 2008 (8). 
Protein content
Total protein concentration was analyzed by using bovine BSA 
as a standard as previously reported (16).
Electrophoresis and Western Blot analysis
40µg of protein from N, Chr and NLMs were submitted to SDS-
PAGE electrophoresis in 10% polyacrylamide slab gel. Elec-
trophoresis and immunoblotting analyses were performed to 
detect lamin B and β-actin according to Bartoccini et al., 2011 
(11). The area density was evaluated by densitometry scanning 
and analysis with Scion Image (11). 
Enzyme activity assay 
SMase, SM-synthase, and PC-PLC activities were assayed as 
previously described by using radioactive SM or PC as sub-
strate (8).
Statistical analysis
Data were expressed as mean ± S.D. of three independent ex-
periments performed in duplicate and t test was used for sta-
tistical analysis. P < 0.001 was considered as statistically signif-
icant. 
Results
Nuclear actin is localized in nuclear lipid microdomains
NM, Chr and NLMs were purified in order to ascertain the sub-
nuclear localization of β-actin. Data of protein content were re-
ported as µg/g liver for H preparations and µg/106 cells for H35 
preparations (Fig.1). 
For this reason to make a real quantitative difference between 
H and H35 preparations was really hard. However, the distribu-
tion of protein content in NM, Chr, and NLM was similar in H 
and H35 cells, about 38-40% in NM, 55-60% in Chr and 1.5% 
in NLM. Then, we set out to investigate the possible presence of 
β-actin in subnuclear preparations. Thus, immunoblotting anal-
ysis was used to highlight simultaneously the presence of β-actin 
NM, Chr, and NLM from H and H35. Since NLMs are specific 
domains of inner nuclear membranes, laminB was analyzed as 
marker of NM and NLM purification; Chr was used as control 
(17). By comparing H and H35 cells, LaminB band resulted simi-
lar in H and H35 cells (Fig. 2a,b). Next, we focused on the results 
showing the localization of β-actin. Surprisingly, it was found to 
localize notably in NLM (Fig. 2a,b). We observed more intense 
staining for β-actin protein in H35 than H (Fig.2a,b).
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Once the nuclear region which was necessary for β-actin lo-
calization was identified, we studied the SM metabolism in 
the different subnuclear fractions. Since PC-PLC activity in 
NLM was present only in trace amount (8), it was used for 
comparison. By using the results in H preparations as controls, 
we showed that in NM of cancer cells the SMase activity un-
changed, SM-synthase was inhibited, and PC-PLC was strong-
ly stimulated (Fig. 3a,b,c). In Chr, SMase activity increased 
and SM-synthase decreased without changes of PC-PLC (Fig. 
3a,b,c). Unexpectedly, in NLM the behavior of SMase and 
Figure 1. Protein content in nuclear membrane (NM), chromatin 
(Chr), and nuclear lipid microdomains (NLM) from hepatocytes and 
H35 hepatoma cells. Left ordinate for NM and Chr, in the right ordi-
nate for NLM. The data are expressed as mean+SD of three expe-
riments performed in duplicate. Significance *P< 0.001 versus NM 
and Chr.
Figure 2. LaminB and β-actin detection in nuclear membrane (NM), 
chromatin (Chr), and nuclear lipid microdomains (NLM) from hepa-
tocytes and H35 hepatoma cells. a) immunoblots of proteins probed 
with specific antibodies and visualized by ECL. Apparent molecular 
weight for LaminB and β-actin was 68KDa, and 43KDa, respectively; 
b) the area density was evaluated by densitometry scanning and 
analysis with Scion Image, the data represent the mean + S.D. of 
three experiments performed in duplicate. (Significance, *P< 0.001 
versus H preparations).
a)
b)
SM-synthase was opposite to that of Chr (Fig.3a,b); PC-PLC 
remained very low (Fig. 3c). 
Discussion
The nucleus contains more than 30 actin-binding proteins 
which are not able to form filaments but had evolved nucle-
ar-specific functions (18). There is an evolving body of litera-
ture supporting a role for β-actin in cell nucleus, as a regulator 
of chromatin remodeling (5), of transcription process (4, 6), 
and of signal transduction from cytoplasm to chromatin (5). 
a)
b)
c)
Figure 3. Sphingomyelinase (a), sphingomyelin-synthase (b), 
and phosphatidylcholine-specific phospholipase C (c) in nuclear 
membrane (NM), chromatin (Chr), and nuclear lipid microdomains 
(NLM) from hepatocytes and H35 hepatoma cells. The activity was 
measured as pmol/mg protein/min, the data represent the mean + 
S.D. of three experiments performed in duplicate. (Significance, *P< 
0.001 versus H preparations).
158  |  VOLUME 1 ISSUE 2  |  MAY 2017    www.eurobiotechjournal.org
Therefore several groups are currently working on the function 
of nuclear β-actin. In this study, we attempted to delineate the 
domains responsible for nuclear β-actin localization. Therefore 
our work has identified for the first time the association of nu-
clear β-actin with specific lipid microdomains present in inner 
NM that acts as platform for Chr anchoring, DNA duplication 
and transcription (8, 9, 10). Therefore it is possible that the 
β-actin, binding to NLM, plays a role of key molecule involved 
in the active chromatin function. Additionally, in this study, we 
uncovered an enrichment of β-actin in the NM of cancer cells 
and consequently a strong enrichment in the NLM. You can 
assume that cancer cells need more nuclear actin attached to 
the NLM for more intranuclear activities. Since SM is the most 
important lipid in NLM in cell nucleus and its metabolism is 
correlated with cell proliferation and cancer (13), we attempted 
to delineate the change of SM metabolism in NLM in associa-
tion with that of β-actin, by supposing that in cancer cells NLM 
might enrich in SM content to facilitate its function as platform 
for nuclear activities. In line with our hypothesis, SM-synthase 
that uses ceramide and PC to form SM freeing diacylglycerol 
(DAG, (14)) increases while SMase that degrades SM freeing 
ceramide (14) decreases. These findings support our recent 
results showing an increase of SM and decrease of ceramide 
content in NLM from H35 cells compared with NLM from H 
(17). Specifically, we showed a shift from 20:0 SM to 16:0 SM 
in NLM from cancer cells and hypothesized that it might influ-
ence the content of functional proteins in the microdomains 
(17).  Furthermore we demonstrated in H35 NLM an increase 
of STAT3, Raf1, and PKCζ proteins involved in hepatocarcino-
genesis (17). Therefore, in this study, we showed for the first 
time the change of SM metabolism in NLM of cancer cells that 
can justify our previous results. We highlighted that the chang-
es of SM in NLM are completely different from those of other 
sub-nuclear districts. In fact, PC-PLC activity notably changes 
in NM. Of note and quite surprisingly, the activity of PC-PLC 
in Chr and NLM from cancer cells are unchanged respect to 
that from normal cells, indicating that only NM is a source of 
DAG from PC in H35 cells. In Chr, SMase activity increases 
and SM-synthase activity decreases; the opposite happens in 
NLM. This apparent contradiction could be explained with the 
different roles of SM in Chr (14, 19) and in NLM (8,9,10).
Taken together, these results strongly suggest that a specific 
regulation of the SM metabolism in NLM is responsible for the 
β-actin anchoring in NLM of cancer cells 
This could suggest a couple of possibilities: a) the SM con-
tent in NLM is critical to the attack of β-actin; or b) the overex-
pression of β-actin in cancer cells requires the high level of SM 
in NLM. These are interesting possibilities that will be investi-
gated in future studies.
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